CG
IMMU

Caprock Group’s Immunomedics Inc IMMU Stock Holding History

Caprock Group’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,395
Closed -$204K – 496
2020
Q3 		$204K Buy
+2,395
New +$121K 0.03% 367

Caprock Group's IMMU Position: Q4 2020 in Review

Caprock Group sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 2,395 shares — an estimated $204K sold.

Caprock Group first reported a position in IMMU in Q3 2020 and held it in 1 quarter. The position peaked at $204K in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Caprock Group reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Caprock Group sold 2,395 Immunomedics Inc shares in Q4 2020, an estimated $204K.
  • Caprock Group first reported a position in Immunomedics Inc in Q3 2020 and held it in 1 quarter.
  • Caprock Group's Immunomedics Inc position peaked at $204K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Caprock Group's 13F filing for Q4 2020, filed 29 Jan 2021.